Durable Complete Response of a Recurrent Mesencephalic Glioblastoma Treated with Trametinib and Low-Dose Dabrafenib in a Patient with Neurofibromatosis Type 1

Patients with neurofibromatosis type 1 (NF1) have an increased lifetime risk for the development of nervous system tumors, including high-grade gliomas (glioblastoma). NF1 is associated with the loss of expression of neurofibromin 1 (NF1 gene product). This hyperactivates the mitogen-activated prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Awada, Gil, Serruys, Daphne, Schwarze, Julia Katharina, Van De Voorde, Lien, Duerinck, Johnny, Neyns, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548872/
https://www.ncbi.nlm.nih.gov/pubmed/33082744
http://dx.doi.org/10.1159/000509773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548872/
https://www.ncbi.nlm.nih.gov/pubmed/33082744
http://dx.doi.org/10.1159/000509773

Ejemplares similares